These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice. Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592 [TBL] [Abstract][Full Text] [Related]
25. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation. Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245 [TBL] [Abstract][Full Text] [Related]
26. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation. Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021 [TBL] [Abstract][Full Text] [Related]
27. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice. Wei LL; Ma N; Wu KY; Wang JX; Diao TY; Zhao SJ; Bai L; Liu E; Li ZF; Zhou W; Chen D; Li K Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2070-2083. PubMed ID: 32762445 [TBL] [Abstract][Full Text] [Related]
28. Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis. Grandoch M; Kohlmorgen C; Melchior-Becker A; Feldmann K; Homann S; Müller J; Kiene LS; Zeng-Brouwers J; Schmitz F; Nagy N; Polzin A; Gowert NS; Elvers M; Skroblin P; Yin X; Mayr M; Schaefer L; Tannock LR; Fischer JW Arterioscler Thromb Vasc Biol; 2016 May; 36(5):e41-50. PubMed ID: 27034473 [TBL] [Abstract][Full Text] [Related]
29. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice. Nasiri-Ansari Ν; Dimitriadis GK; Agrogiannis G; Perrea D; Kostakis ID; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E Cardiovasc Diabetol; 2018 Jul; 17(1):106. PubMed ID: 30049285 [TBL] [Abstract][Full Text] [Related]
30. Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice. Vendrov AE; Stevenson MD; Alahari S; Pan H; Wickline SA; Madamanchi NR; Runge MS J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079564 [TBL] [Abstract][Full Text] [Related]
32. The P2Y Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380 [TBL] [Abstract][Full Text] [Related]
33. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843 [TBL] [Abstract][Full Text] [Related]
34. DKK3 (Dickkopf 3) Alters Atherosclerotic Plaque Phenotype Involving Vascular Progenitor and Fibroblast Differentiation Into Smooth Muscle Cells. Karamariti E; Zhai C; Yu B; Qiao L; Wang Z; Potter CMF; Wong MM; Simpson RML; Zhang Z; Wang X; Del Barco Barrantes I; Niehrs C; Kong D; Zhao Q; Zhang Y; Hu Y; Zhang C; Xu Q Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):425-437. PubMed ID: 29284609 [TBL] [Abstract][Full Text] [Related]
35. PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice. Jones SM; Mann A; Conrad K; Saum K; Hall DE; McKinney LM; Robbins N; Thompson J; Peairs AD; Camerer E; Rayner KJ; Tranter M; Mackman N; Owens AP Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1271-1282. PubMed ID: 29599135 [TBL] [Abstract][Full Text] [Related]
36. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4. Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793 [TBL] [Abstract][Full Text] [Related]
37. Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression. Qi J; Cui J; Mi B; Yan X; Xu W; Ma H; Zhang Q; Xu F Cardiovasc Ther; 2020; 2020():1926249. PubMed ID: 32328171 [TBL] [Abstract][Full Text] [Related]
38. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions. Barnes RH; Akama T; Öhman MK; Woo MS; Bahr J; Weiss SJ; Eitzman DT; Chun TH J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735290 [TBL] [Abstract][Full Text] [Related]
39. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice. Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052 [TBL] [Abstract][Full Text] [Related]
40. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]